Newsletter registration

Austria.
Where Your Profits Grow Sky High.

The Upper Austrian startup GENSPEED® Biotech develops a rapid test system for hospital bacteria and periodontal pathogens

GENSPEED®-Technology © GENSPEED® Biotech GmbH

Infections caused by antibiotic-resistant hospital bacteria that occur during hospital stays or infections with periodontal pathogens can result in serious consequences for affected patients. Both the detection of hospital bacteria in hospitals and the detection of periodontal pathogens in the dental field can take several days. The patient samples must either be examined through the use of lengthy in-house analyses or sent to external laboratories. With the rapid tests from GENSPEED® Biotech, hospital bacteria can be detected in the hospital laboratory in just 100 minutes, and periodontal pathogens can be detected in just 20 minutes directly at the dentist's practice. In both cases, rapid diagnosis allows for an immediate, targeted start of treatment. The GENSPEED immediate diagnosis system is a patented technology based on microfluid biochips, miniaturized optical detection and automation. In other words, the sample (e.g. from a nasal smear) is processed using standard methods and dripped into a so-called microfluid chip. No further intervention is required by the user, who can read the test result on the computer after a short time.

More information is available here.

 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Russian-Austrian Business Council

    23.11.2017, Kazan, Russian Federation

  • Innovation@Austria? Invest in the technology HotSpot Carinthia.

    29.11.2017 / 10:00, Ljubljana, Slovenia

Austria Map

Find the perfect location for your company

We are lucky to benefit from a lot of reserach incentives here in Austria. We are very proud to be here as Austria is an ideal location for research.

TachoEASY Austria

Logo
More testimonials

news from the business location Austria

Viennese researchers: New hope for treatment of aggressive leukaemia

Up until now, the rare and highly aggressive form of blood cancer called T-PLL leukaemia could not be sufficiently treated in the past.

Highly popular: Austrian startup scene improves connections to Asian hotspots

What do Israel, Japan, Singapore, Hong Kong and South Korea have in common? They belong to the target countries of the Global Incubator Networks (GIN). Over the last two years GIN has been promoting investments in and from these hotspots – as a one-stop-shop for investors, startups and incubators.

More news All blog posts